Khodir A E, Ghoneim H A, Rahim M A, Suddek G M
Department of Pharmacology and Toxicology, Faculty of Pharmacy, Delta University, Mansoura, Egypt.
Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt.
Hum Exp Toxicol. 2016 Apr;35(4):388-97. doi: 10.1177/0960327115591372. Epub 2015 Jun 18.
This study investigates the possible protective effects of montelukast (MNT) against lipopolysaccharide (LPS)-induced cardiac injury, in comparison to dexamethasone (DEX), a standard anti-inflammatory. Male Sprague Dawley rats (160-180 g) were assigned to five groups (n = 8/group): (1) control; (2) LPS (10 mg/kg, intraperitoneal (i.p.)); (3) LPS + MNT (10 mg/kg, per os (p.o.)); (4) LPS + MNT (20 mg/kg, p.o.); and (5) LPS + DEX (1 mg/kg, i.p.). Twenty-four hours after LPS injection, heart/body weight (BW) ratio and percent survival of rats were determined. Serum total protein, creatine kinase muscle/brain (CK-MB), alkaline phosphatase (ALP), and lactate dehydrogenase (LDH) activities were measured. Heart samples were taken for histological assessment and for determination of malondialdehyde (MDA) and glutathione (GSH) contents. Cardiac tumor necrosis factor α (TNF-α) expression was evaluated immunohistochemically. LPS significantly increased heart/BW ratio, serum CK-MB, ALP, and LDH activities and decreased percent survival and serum total protein levels. MDA content increased in heart tissues with a concomitant reduction in GSH content. Immunohistochemical staining of heart specimens from LPS-treated rats revealed high expression of TNF-α. MNT significantly reduced percent mortality and suppressed the release of inflammatory and oxidative stress markers when compared with LPS group. Additionally, MNT effectively preserved tissue morphology as evidenced by histological evaluation. MNT (20 mg/kg) was more effective in alleviating LPS-induced heart injury when compared with both MNT (10 mg/kg) and DEX (1 mg/kg), as evidenced by decrease in positive staining by TNF-α immunohistochemically, decrease MDA, and increase GSH content in heart tissue. This study demonstrates that MNT might have cardioprotective effects against the inflammatory process during endotoxemia. This effect can be attributed to its antioxidant and/or anti-inflammatory properties.
本研究调查了孟鲁司特(MNT)与标准抗炎药地塞米松(DEX)相比,对脂多糖(LPS)诱导的心脏损伤可能具有的保护作用。将雄性Sprague Dawley大鼠(160 - 180 g)分为五组(每组n = 8):(1)对照组;(2)LPS组(10 mg/kg,腹腔注射(i.p.));(3)LPS + MNT组(10 mg/kg,口服(p.o.));(4)LPS + MNT组(20 mg/kg,口服);(5)LPS + DEX组(1 mg/kg,腹腔注射)。LPS注射后24小时,测定大鼠的心/体重(BW)比值和存活率。检测血清总蛋白、肌酸激酶同工酶(CK-MB)、碱性磷酸酶(ALP)和乳酸脱氢酶(LDH)活性。采集心脏样本进行组织学评估,并测定丙二醛(MDA)和谷胱甘肽(GSH)含量。通过免疫组织化学法评估心脏肿瘤坏死因子α(TNF-α)的表达。LPS显著增加了心/体重比值、血清CK-MB、ALP和LDH活性,降低了存活率和血清总蛋白水平。心脏组织中MDA含量增加,同时GSH含量降低。LPS处理大鼠心脏标本的免疫组织化学染色显示TNF-α高表达。与LPS组相比,MNT显著降低了死亡率,并抑制了炎症和氧化应激标志物的释放。此外,组织学评估表明MNT有效地保留了组织形态。与MNT(10 mg/kg)和DEX(1 mg/kg)相比,MNT(20 mg/kg)在减轻LPS诱导的心脏损伤方面更有效,这通过TNF-α免疫组织化学阳性染色减少、心脏组织中MDA降低和GSH含量增加得以证明。本研究表明,MNT可能对内毒素血症期间的炎症过程具有心脏保护作用。这种作用可归因于其抗氧化和/或抗炎特性。